Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent post VF8! One thing not mentioned is the subject to be taken up I believe at the Sep 25th hearing: Anti-trust violations by JnJ. If found guilty, they must pay triple damages. This could easily exceed the bond value!
When you eliminate most everything you've been selling to this point it definitely hurts-but puts them in a great position to ramp up Genstrip sales big time! And hopefully tapping into a $12M bond won't hurt either!!
I see the 10Q is out now on the Schwab site and the findings of the USPTO are in print.
Great stuff! And don't forget the part from the post on the other board about a possible stay of the entire JnJ suit being issued in between these 2 hearings at which time settlement takes place.
BTW, isn't the 10Q due out tomorrow? And if so, I wonder if the USPTO decision will be discussed in it? I would hope so.
Quite a failure, huh? Wish I had several more of these "failures." Read on from the Q>>
"For the six months ended June 30, 2013, CUI Global produced consolidated total revenues of $28,210,451. The numbers demonstrate that gross revenues for the Second Quarter ($18,151,091) grew 80% sequentially from First Quarter revenues ($10,059,360) and 81% year-over-year, when compared to Second Quarter 2012 ($10,011,758), before the acquisition of Orbital-UK and associated accretive revenues.
The company had $28,105,549 of cash and cash equivalents as of June 30, 2013 – an increase of more than $25,000,000 since December 31, 2012 ($3,039,840).
The company earned a net profit of $0.02 earnings per share (EPS) for the quarter ended June 30, 2013. The earnings before interest, taxes, depreciation and amortization (EBIDTA) per share for the second quarter were $0.08.
In addition, as an operating unit, the power and electro-mechanical segment (CUI Inc and CUI Japan) posted record YTD revenues of $22,253,366, which represented a $3,771,845 (20%) increase as compared to the same period in 2012.
The sales order back log at June 30, 2013 was a consolidated $38.2 million, a $26.0 million (200%) increase from the June 30, 2012 back log balance of $12.2 million (before the acquisition of Orbital-UK and associated accretive revenues).
"This is the first consolidated reporting period following our acquisition of Orbital-UK and the results are quite compelling," explained William Clough, CUI Global's president & CEO. "The sequential growth in revenue; the dramatic increase in customer back orders; and our turn to profitability all demonstrate the tangible results of this immediately accretive acquisition and our continuing efforts, now through CUI, Inc., CUI Japan and Orbital-UK, to increase our penetration into both the electronics and natural gas markets."
"Moreover, the 200% increase in sales order back log, year-to-year, ensures us of a robust delivery schedule for the Third Quarter of 2013."
Oh, Rats!! I already have plans to be out for a week each in Oct and Nov. If I had only known :) Somehow I think things will go fine regardless of my status.
Regarding JnJ's current quarter performance, it will be interesting to see how much of the lost revenues will make their way into DECN's coffers??? DECN significantly increasing revenue could make any "deal" that much sweeter.
Your numbers are what I've had in mind: $8-10/share is what I'm looking for if all goes according to plan.
Let's hear it for the small companies-especially DECN!
I concur-yet they could have made this go away for a lot less than it will probably cost them now or in the future. Their arrogant approach keeps costing them more and more and more, which ultimately should benefit the company and shareholders.
Throwing in the towel may be prudent from a business perspective, but I wouldn't expect them to do so due to their corporate arrogance.
You wouldn't be pumping the stock now, would you Mr. S :) ? It would be great if this happens-plus a lot more buying soon. Don't know about any of this-just waiting for the courts to rule. That's the main event, and that will determine the company's future!
Thanks for providing feedback on the good news, Mr S! Soon could be this week-I have a feeling it will be next. Since I've been a stockholder over 4 years now, I don't think waiting another week or 2 will kill me :) Anticipating a good outcome.
I agree with Leirum. Someone is keeping this down. Shares are appearing out of nowhere to sell in the .25-.27 range. Over 90,000 shares sold in just a few minutes...Ugh
Judges are political animals. I think the judge didn't want to deliver bad news to JnJ (somebody knows something :), nor did he want to be removed from this case-not a good career move. So he bailed! All IMO.
Thx for the informative response. If the original District Judge's ruling was even close, this case wouldn't have been reassigned. Reading all the tea leaves, it appears we'll know something soon. All IMO.
Seems like this can only be good. Hopefully the Patent Court will publish their ruling in the next week, a ruling I fully expect to be in favor of DECN. I guess time will tell.
Great article! Here's my favorite part:
"JNJ practically has a monopoly on this market. However, if DECN is able to successfully get its product into the hands of those who need it, it will simultaneously save diabetes patients money while making investors rich. "
A winner all the way around, except for JnJ !
I like this part of the history of Alere from answers.com. The stock went from $1.50 to $17+ then $25+:
LifeScan began phasing out its own diabetes test kits, as the ones made by Inverness were much faster. Inverness brought out the One-Touch Ultra blood sugar test kit in 2000, which gave results in only five seconds. Older test kits took two minutes to perform their analysis.
LifeScan was more dependent on Inverness as it let its own products go by the wayside. Its market share was squeezed by competitors, and it lost ground. In 2001 LifeScan purchased the diabetes monitoring business of its supplier, Inverness. The deal was worth $1.33 billion, paid for with Johnson & Johnson stock.
Read more: http://www.answers.com/topic/inverness-medical-innovations-inc#ixzz2Wmp3KfHg
Looking very promising indeed!!
It looks like the co can keep selling Genstrip and that's a good thing!
No anger, premo, just pointing out that you've presented your points with little basis in fact-except Your Honest Opinion. Your negative bias against DECN is pretty obvious IMHO-I wonder where that comes from???
Good to hear from you ksv. I don't remember where I read it (some time ago), but I am of the opinion that other products are in the pipeline that would be used in meters for other major companies.
I think that's reasonable-and the longer this goes the better-as long as progress is being made. I believe May could be a big month since that's when the 1st qtr #s come out. We could have a much better picture by then.
What do you think a decent offer would be?
That's great news- and much more to come!!
1. Numerous others have failed with generic strips. It's not a generic, it's an alternative strip
2. DECN track record of failure Like FDA approval in a very difficult regulatory environment?
3. Genstrips are for meters purchased before 2010 How many are still in use?
4. It is already well into 2013 And your point is??
5. Meters are replaced often Do you have evidence you can share that this is true?
6. Past record of management team It seems like KB and co. have taken DECN from the shambles of past regimes and made it something to put hope in.
7. Limited Distribution Network (almost non existent) i.e. like Walmart, right?
8. JnJ Patent infringement There is no infringement at this time-that's why it's in court, correct?
9. Shasta/DECN hide and seek court delays It seems like the Court ordered delays last year, not Shasta
10. Just not a Big Deal That's why JnJ is pursuing this so aggressively, right?
It seems to me you've made numerous negative assumptions against DECN above w/o any basis of fact, and you've presented them as facts. From where does your negative bias come?
Progress--as per a post on the yahoo mb, Genstrip is now available on Amazon! Check it out.
However, shipping product does. Hide and watch, IMO.
That is great news! Congrats to all longs!!!!
Yep, it does look that way.
We'll see....
I received the card in the mail. I called them Monday and didn't learn a whole lot except that they were hired by the company to do some IR work, and reach out to shareholders. After speaking with Zach, I felt like his main attempt was to try to get me on his mailing list for future stock trading tips. He kept saying how well he thought this stock would do, especially due to only appx 10M shares outstanding, if FDA approval was received. Frankly, I wasn't too impressed with the whole interaction.
Quite a bit of buying before market open...hmmmmmm.
Not only do they have great products, but are in a good position to be an industry driver. This could be good, really good. I'll hold a core position for a long time, although I hope to see the first installment of pps increase this Fall. Can't wait to enjoy this over the long haul with you and other longs!
That's why I'm adding now while it's cheap, so I can sell some at .06-.12, then have a good amount of shares to ride for the long haul.
logytwo, are you the same long term investor I've seen on the CUI mb, and formerly Waytronix/NMMI?? Regardless, welcome here. This is going to be a good one IMO!
I think it will do really well in 3-5 years, but I think way before $1/sh with the current share structure, there will be a RS to clean up the high OS,followed by a listing on one of the big boards. Maybe 1:50 RS?? I don't know...all IMO. To get real benefit, we need to have some share appreciation before a RS-even at $.06/sh a 1:50 RS gives us a $3 pps.
Great news! Just picked up some more cheap shares :)
Great news for the long term! Don't think anything short of revs will move this stock much in the near term, unfortunately.
It now looks like dueling lawsuits!